Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to evaluate the outcomes of LPD versus OPD in non-pancreatic periampullary adenocarcinoma


Clinical Trial Description

The aim of this study was to evaluate the outcomes of LPD versus OPD in non-pancreatic periampullary adenocarcinoma ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05788029
Study type Interventional
Source Tongji Hospital
Contact Hang Zhang
Phone +8602783665314
Email zhanghang@hust.edu.cn
Status Not yet recruiting
Phase N/A
Start date December 2023
Completion date December 2025

See also
  Status Clinical Trial Phase
Recruiting NCT03724994 - Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer
Completed NCT01229111 - Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers Phase 2
Completed NCT00983268 - Capecitabine, Vorinostat, and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer Phase 1
Completed NCT00987766 - Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer Phase 1
Recruiting NCT01811277 - SOX Sequential S-1 in Advanced Biliary Tract Carcinoma(BTC)and Pancreatic Cancer Phase 2
Active, not recruiting NCT01781728 - Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Phase 2
Terminated NCT00832637 - Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers Phase 2
Recruiting NCT02757859 - High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery N/A